Edmonton, Canada

Ole Hindsgaul

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ole Hindsgaul. Retrieved from https://idiyas.com/inventor/ole-hindsgaul-po1phwtr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Ole Hindsgaul: Innovator in Compound Library Screening

Introduction

Ole Hindsgaul is an accomplished inventor based in Edmonton, Canada. He has made significant contributions to the field of compound library screening, particularly through his innovative patent, which focuses on enhancing the efficiency of identifying compounds that bind to target receptors.

Latest Patents

Ole Hindsgaul holds a patent titled "Apparatus For Screening Compound Libraries." This invention discloses apparatus for screening compound libraries using frontal chromatography in combination with mass spectrometry. The technology is designed to identify and rank members of the library that bind to a target receptor. Additionally, the apparatus allows for rapid screening of a compound library to determine if any member has a higher affinity for the target receptor compared to a pre-selected indicator compound. Notably, he has 0 patents registered under his name.

Career Highlights

Ole Hindsgaul is currently employed at Transition Therapeutics, Inc., where he continues to work on innovative solutions in the field of drug discovery and development. His expertise in mass spectrometry and chromatography has positioned him as a valuable asset in the research community.

Collaborations

One of his notable collaborators is David C. Schriemer, with whom he has worked closely on various projects related to compound screening and receptor binding.

Conclusion

Ole Hindsgaul's contributions to the field of compound library screening demonstrate his commitment to advancing drug discovery technologies. His innovative approaches have the potential to significantly impact the efficiency of identifying effective compounds for therapeutic use.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…